SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001698530-23-000089
Filing Date
2023-08-11
Accepted
2023-08-11 16:18:03
Documents
14
Period of Report
2023-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20230811.htm   iXBRL 8-K 25951
2 EX-99.1 a8kq22023exhibit991.htm EX-99.1 84869
6 exicureimage1a10.gif GRAPHIC 2794
  Complete submission text file 0001698530-23-000089.txt   252369

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20230811.xsd EX-101.SCH 1907
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20230811_lab.xml EX-101.LAB 24833
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20230811_pre.xml EX-101.PRE 13047
8 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20230811_htm.xml XML 2802
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 231164387
SIC: 2834 Pharmaceutical Preparations